Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats

British Journal of Pharmacology
M J CurtisT Yuswack

Abstract

Two analogues of verapamil, ronipamil and anipamil, were tested for their ability to reduce arrhythmias induced by occlusion of the left anterior descending coronary artery in conscious rats. Only anipamil (50 and 150 mg kg-1 orally) produced a statistically significant reduction in arrhythmias; it was most effective against ventricular fibrillation. Ronipamil at the same doses had limited antiarrhythmic actions. Only anipamil delayed the development of ECG signs of ischaemia, while both drugs reduced the magnitude of such changes. Anipamil has a more favourable ratio of antiarrhythmic to hypotensive effects when compared with verapamil.

Citations

Jan 1, 1985·Molecular Aspects of Medicine·J H BottingM J Walker
Dec 1, 1989·British Journal of Pharmacology·B A MacLeodM J Walker
Dec 1, 1989·British Journal of Pharmacology·R TabrizchiM J Walker
May 1, 1988·British Journal of Pharmacology·J S Dillon, W G Nayler
Apr 30, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·M K PugsleyM J A Walker
Oct 15, 1988·Experientia·P Honegger, P Werffeli
Feb 6, 2018·Advanced Pharmaceutical Bulletin·Tahereh Eteraf-OskoueiMoslem Najafi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.